Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Big Health Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
This study will explore whether sleep in stroke survivors is improved with digital cognitive behavioural therapy for insomnia (Sleepio), in comparison to treatment as usual, and will explore whether changes in sleep relate to changes in overnight consolidation of motor learning.
Stroke is one of the leading causes of adult disability. Rehabilitation of movement after stroke depends on motor learning. Motor learning involves not only improvement during practice but also offline improvement, or consolidation, that occurs after practice. Consolidation of learning depends on good sleep quality. However, sleep is disrupted long-term after stroke and patients with poorer sleep show worse rehabilitation outcomes.
Cognitive behavioural therapy for insomnia (CBT) is the recommended first line treatment for sleep problems. "Sleepio" is a digital CBT programme which is effective across a range of clinical populations. This study aims to test the efficacy of digital CBT for reducing insomnia symptoms after stroke, in comparison with usual care alone. To explore the possibility that sleep interventions might enhance rehabilitation outcomes via their impact on consolidation of motor learning, the study will additionally test for differences in consolidation between groups, and explore whether changes in sleep measures are associated with changes in consolidation.
Participants will be randomised to either receive digital CBT for insomnia (in addition to usual care) or receive treatment as usual alone (2:1 treatment to control ratio). The primary outcome is the score on the 8-item Sleep Condition Indicator, 10 weeks following randomisation. Secondary outcomes include behavioural measures of overnight motor consolidation assessed as the change in motor task performance from training to retest, sleep disruption assessed with actigraphy, and depression and fatigue using the Patient Health Questionnaire (PHQ9) and the Fatigue Severity Scale respectively.
In addition to this, to explore the feasibility of delivering rehabilitation following the sleep improvement programme, an optional 4 weeks of upper limb motor training at home will be offered to all participants (regardless of group allocation) after follow-up. Outcomes of adherence to the training and upper limb function will be assessed.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Behavioural: Digital cognitive behavioural therapy for insomnia | Experimental | 6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online. |
|
| Treatment as usual | No Intervention | Participants will receive treatment as usual. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Digital Cognitive Behavioural Therapy for Insomnia | Behavioral | 6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online, in addition to usual care. |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep Condition Indicator | Questionnaire assessing self-reported insomnia symptoms, range 0-32, higher numbers indicate less symptoms of insomnia | 10 weeks after randomisation |
| Measure | Description | Time Frame |
|---|---|---|
| Change in motor performance from training to retest | Behavioural motor consolidation assessment, assessed as accuracy (range 0-50, higher numbers indicate better accuracy of motor performance) | 10 weeks after randomisation |
| Patient Health Questionnaire |
| Measure | Description | Time Frame |
|---|---|---|
| Adherence of at home motor training | Assessment of number of sessions performed, number of repetitions etc. | 14 weeks following randomisation |
| Upper limb ability | Assessed with Action Research Arm Test, range 0-57, higher score indicates better upper limb ability |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Melanie K Fleming, Dr | Contact | 01865 611 461 | melanie.fleming@ndcn.ox.ac.uk | |
| Barbara Robinson | Contact | sleep-win@ndcn.ox.ac.uk |
| Name | Affiliation | Role |
|---|---|---|
| Melanie K Fleming, Dr | University of Oxford | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Oxford | Recruiting | Oxford | OX39DU | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37024247 | Derived | Weightman M, Robinson B, Fallows R, Henry AL, Kyle SD, Garratt E, Pick A, Teal R, Ajina S, Demeyere N, Espie CA, Seymour B, Johansen-Berg H, Fleming MK. Improving sleep and learning in rehabilitation after stroke, part 2 (INSPIRES2): study protocol for a home-based randomised control trial of digital cognitive behavioural therapy (dCBT) for insomnia. BMJ Open. 2023 Apr 6;13(4):e071764. doi: 10.1136/bmjopen-2023-071764. |
Not provided
Not provided
De-identified data are available upon reasonable request
Following publication of results
Available upon reasonable request
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
A randomised controlled trial with two parallel study arms: (1) digital cognitive behavioural therapy for insomnia (experimental condition), and (2) treatment as usual (control condition). Randomisation will be using a 2:1 ratio (experimental:control), within minimisation of between group differences in age, sex, baseline Sleep Condition Indicator score and time since stroke.
Not provided
Not provided
Randomisation and facilitation of the intervention will be performed by a research assistant, and the person analysing the data will be blinded to group allocations.
|
Questionnaire assessing symptoms of depression, range 0-20, higher values indicate more depressive symptoms |
| 10 weeks after randomisation |
| Fatigue Severity Scale | Questionnaire assessing fatigue, range 9-63, higher score indicates more severe fatigue | 10 weeks after randomisation |
| Actigraphy | Wearable activity monitor used for assessing sleep disruption (Total Sleep Time, Wake After Sleep Onset, sleep fragmentation) | 10 weeks after randomisation |
| 14 weeks following randomisation |
| Upper limb function | Assessed with Box and Blocks Test, scored as the number of blocks transferred in 60 seconds | 14 weeks following randomisation |
| Upper limb dexterity | Assessed with Nine hole peg test, scored as the number of pegs placed in 30 seconds | 14 weeks following randomisation |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |